Iridium catalyst activates chemotherapy drug directly at targeted cancer cells

NewsData.net brief · 1h ago · 1 min read · via phys.org

Conventional chemotherapy treatments often attack not only cancer cells but also healthy tissue, leading to severe side effects such as hair loss or nausea. The team led by Dr. Thomas Ward from the Department of Chemistry and the Swiss Nanoscience Institute (SNI) at the Universit

Conventional chemotherapy treatments often attack not only cancer cells but also healthy tissue, leading to severe side effects such as hair loss or nausea. The team led by Dr. Thomas Ward from the Department of Chemistry and the Swiss Nanoscience Institute (SNI) at the Universit This story matters for Science & Discovery readers tracking science. Reported by phys.org. Read the full original at the source link below.

Originally reported by phys.org. NewsData.net curates and briefs the science & discovery stories that matter. Our editorial policy →
Get the daily science & discovery signal

More from NewsData.net

Related ventures